{
  "zip": "59120",
  "sector": "Healthcare",
  "fullTimeEmployees": 203,
  "longBusinessSummary": "Genfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions for metabolic, inflammatory, autoimmune, and fibrotic diseases affecting primarily the liver and gastroenterology. The company's lead products include Elafibranor, which is in pivotal Phase III clinical trials for the treatment of nonalcoholic steatohepatitis (NASH), as well as completed Phase II clinical trial to treat patients with primary biliary cholangitis; and Nitazoxanide that is in Phase II proof-of-concept clinical trial for the treatment of NASH-induced significant or severe fibrosis. It is also developing in-vitro diagnostic tests for the identification of patients with NASH; NIS4 for identifying patients with NASH and fibrosis; and TGFTX1 preclinical program for treating psoriasis or respiratory conditions, such as neutrophilic asthma, chronic obstructive pulmonary disease (COPD), and the asthma-COPD overlap syndrome. Genfit SA was founded in 1999 and is headquartered in Loos, France.",
  "city": "Loos",
  "phone": "33 3 20 16 40 00",
  "country": "France",
  "companyOfficers": [],
  "website": "http://www.genfit.com",
  "maxAge": 1,
  "address1": "Parc EurasantE",
  "fax": "33 2 20 16 40 01",
  "industry": "Biotechnology",
  "address2": "885, Avenue EugEne AvinEe",
  "previousClose": 5.53,
  "regularMarketOpen": 5.53,
  "twoHundredDayAverage": 4.9325323,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 5.53,
  "navPrice": null,
  "averageDailyVolume10Day": 25,
  "totalAssets": null,
  "regularMarketPreviousClose": 5.53,
  "fiftyDayAverage": 5.190121,
  "trailingAnnualDividendRate": null,
  "open": 5.53,
  "averageVolume10days": 25,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.186414,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 5.53,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 30,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 211395872,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 196,
  "priceToSalesTrailing12Months": null,
  "dayLow": 5.53,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 30,
  "fiftyTwoWeekHigh": 21.5,
  "forwardPE": -2.143411,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 3.75,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 5.53,
  "exchange": "PNK",
  "shortName": "GENFIT",
  "longName": "Genfit SA",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "GNFTF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_9683234",
  "uuid": "5b7ae37c-dd0d-378c-898f-e7cd85104c3d",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": -1.7198199,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": -2.58,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 38800000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 2.616,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.04753,
  "netIncomeToCommon": null,
  "trailingEps": -2.635,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 2.1139145,
  "heldPercentInsiders": 0.065910004,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 36887838,
  "enterpriseValue": 214624384,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1389225600,
  "lastSplitFactor": "1009:1000",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 5.53,
  "logo_url": "https://logo.clearbit.com/genfit.com"
}